New cosmetic use of closed-porosity porous spheres of metal oxide
Patent Information
- Application Number
- EP2023706387
- Authority / Receiving Office
- EP · EP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-01-18
- Filing Date
- 2023-01-18
- Publication Date
- 2024-11-27
AI Technical Summary
Existing cosmetic solutions fail to effectively mask unsightly skin and hair imperfections, such as wrinkles and discoloration, while maintaining a natural appearance and comfort, especially for diverse skin types, due to limitations in optical properties and formulation stability.
The use of closed porosity porous spheres made of metal oxides, which have a majority of closed pores, providing enhanced light diffusion and reflection, allowing for a 'soft focus' effect, and are easy to formulate, stable, and inert, suitable for various skin types, including sensitive and hyperseborrhoeic skin.
These spheres significantly improve the appearance of skin and hair by minimizing imperfections, providing a natural, radiant look, and enhancing comfort without irritation, suitable for all skin types and formulations, including makeup and dermatological compositions.
Smart Images

Figure IMGF000055_0001 
Figure IMGF000056_0001 
Figure IMGF000056_0002
Abstract
Description
[0001] New cosmetic use of closed-porosity porous spheres of metal oxide
[0002] Technical Field
[0003] The present invention relates to the cosmetic use of closed-porosity porous spheres of metal oxide for improving the aesthetic appearance and comfort of the skin, skin appendages, in particular hair and / or mucous membranes, as well as said cosmetic compositions and the resulting cosmetic treatment methods. The present invention also relates to pharmaceutical compositions, in particular dermatological compositions, comprising the closed-porosity porous spheres of metal oxide for improving the comfort of the skin, skin appendages and / or mucous membranes presenting a pathological condition.
[0004] Visibly improving the appearance of skin and hair is one of the main challenges in cosmetics. Consumers of cosmetic products are constantly in demand for cosmetic solutions to effectively mask the signs deemed unsightly by the skin and / or hair. These signs appear naturally with aging but can also result from chronic exposure to various factors. These can include environmental factors such as pollution, wind, climatic variations, particularly excessive temperature variations due to air conditioning, and dryness. They can also include aggressive factors of a mechanical nature such as shaving, rubbing and hair removal, and / or aggressive factors of a chemical nature such as hair treatments, including (de)bleaching, perming and straightening, detergents, and exfoliating treatments.These factors cause damage to the skin, skin appendages and / or mucous membranes, resulting in visible manifestations that are often considered unsightly. Intrinsic factors contribute to their appearance, including stress, hormonal fluctuations, weight gain, dieting, dehydration and aging. Genetics, including skin type (sensitive, hyperseborrheic, reactive, etc.) and ethnic origin, such as Caucasian, Asian or African, also play an important role in the appearance of certain manifestations.
[0005] Unsightly skin manifestations include wrinkles and fine lines, such as frown lines and crow's feet. They can be expression lines or aging lines. These are initially superficial and then become deeper, such as nasolabial folds. Skin manifestations also include signs of volume loss, including sagging of the skin, loosening of facial contours leading to sagging of facial features, which gives a sad or tired appearance, or loss of density, which results in thinner, weakened skin, which is accompanied by a loss of radiance and / or a so-called dull complexion.Thus, unsightly skin manifestations also include manifestations of color, shine and pigmentation such as loss of uniformity of complexion, radiance, dark circles, bags, redness, brown spots or age spots or white spots including vitiligo, rosacea, pregnancy mask, melasma, nevus, angioma. They also include skin imperfections such as blackheads, visible pores, pimples, scars including acne marks, burns, injuries, stretch marks but also rough skin and peeling. At the level of the mucous membranes, unsightly manifestations are generally signs of dehydration such as scales and / or cracks. At the level of the hair, unsightly manifestations are generally dull, depigmented, brittle, difficult to style hair, especially unruly, with split ends.
[0006] These manifestations, particularly those that appear on the face and eyes, are particularly perceived as unsightly by consumers. While some of them can be corrected by cosmetic surgery, this is not always the case, and the result is sometimes unsatisfactory because it is partial, perceived as unnatural, irritating, or even painful, and often expensive. Many consumers cannot afford it or are opposed to it. Many cosmetic alternatives exist to mask or reduce these undesirable manifestations. Makeup, particularly foundations, aim to provide a solution to hide wrinkles and even out the complexion. But consumers are also looking for a healthy glow that remains natural, without pigment transfer onto clothing, as well as a well-being effect upon application.
[0007] The soft focus effect in the cosmetics industry is used in anti-aging creams and makeup. Skin surface imperfections such as fine lines and wrinkles make the skin appear uneven by trapping light in the micro-crevices formed by the wrinkles. The trapped light is then absorbed and generates dark spots that will appear on the skin's surface. There are special pigments and / or particles, e.g., transparent alumina platelets coated with a thin layer of titanium dioxide, designed to create this soft focus effect by uniformly diffusing light on the skin's surface. Fine lines and wrinkles are masked by remaining fairly translucent across the entire skin surface, which gives the skin a natural appearance while diminishing the appearance of imperfections. To achieve this soft focus effect, the pigments / particles must exhibit optical properties of:
[0008] - high total transmittance (overall light transmission) to give a natural appearance and
[0009] - maximum haze to create a translucent and uniform light distribution. This will greatly minimize the appearance of fine lines and wrinkles, helping older consumers look younger and have more radiant skin.
[0010] Total transmittance is influenced by light absorption and reflection, while haze is influenced by light scattering. Haze is an important appearance attribute because it directly affects human perception and plays a significant role in consumer demand. It reflects the degree of haze or blurring of a transparent material. Its value is expressed as a percentage. The higher the value, the greater the haze.
[0011] Porous metal oxide spheres have already been described in patent applications WO2020 / 183108 and WO2020 / 182936 in the context of cosmetic applications and in particular for improving the appearance of the skin, skin appendages and / or mucous membranes, in particular by masking unsightly manifestations. However, these spheres have open porosity and therefore do not have closed pores as illustrated in Figure 1B. The % of closed pores by volume of these spheres is thus less than 5%.
[0012] The inventors surprisingly discovered that porous spheres with closed porosity of metal oxide had an improved effect on masking imperfections compared to the porous spheres with open porosity of the prior art. Indeed, such spheres have a higher total transmittance and haze value, thus making it possible to improve their blurring / masking property ("soft focus"). In addition, such spheres are easier to formulate because the external formulation medium, and in particular the compounds present in this medium, cannot penetrate them, which allows them to keep a constant net refractive index regardless of the formulation medium and / or the type of formulation and therefore to avoid a modification of their optical property and therefore of their masking property depending on the formulation medium used. These spheres are in particular illustrated in Figure 1B.
[0013] Statement of the invention
[0014] The present invention thus aims to meet this constant need for a cosmetic alternative to improve the appearance of the skin, skin appendages and / or mucous membranes, in particular by masking unsightly manifestations, advantageously by a “soft focus” effect. The present invention also aims to provide a new cosmetic ingredient which is also easy to formulate, and devoid of side effects, in particular which does not induce irritation on the skin. The spheres according to the invention have the unique capacity to reflect and diffuse light and thus make it possible to smooth the surface of the skin, skin appendages and / or mucous membranes and thus to hide their unsightly manifestations and increase their radiance. They also give a soft and silky feel to the composition which contains them.
[0015] The spheres according to the invention offer the advantage of being suitable for all skin types regardless of skin type, complexion and radiance. Another advantage of the present invention is that the spheres are highly stable and can be used in powder form or as a composition. They are inert, which makes it easy to formulate them in any type of cosmetic or dermatological composition, whether lipophilic or hydrophilic.
[0016] Another advantage is that the spheres can be used with the conventional ingredients of cosmetic compositions, in particular makeup and / or cosmetic care, in particular pigments or coloring agents to help mask unsightly manifestations, in particular imperfections. According to an advantageous embodiment, the spheres according to the invention can be used in foundations and / or makeup and / or care products.
[0017] The present invention thus relates to the non-therapeutic cosmetic use of porous spheres with closed porosity comprising a metal oxide to improve the appearance and / or comfort of the skin, skin appendages, in particular hair, and / or mucous membranes.
[0018] According to the invention, the term “porous spheres with closed porosity” means spheres in which the majority (more than 50% by volume) of the pores are made up of closed pores, i.e. having no opening to the outside of the sphere. In particular, at least 90% by volume of the pores are closed pores, more advantageously at least 95% by volume of the pores are closed pores, even more advantageously at least 99% by volume of the pores are closed pores. The % by volume of closed pores is measured based on the images obtained by scanning electron microscopy (SEM) of the spheres. It can be defined as the ratio between the number of closed pores / the total number of pores. Since the volume of each pore, whether open or closed, is identical, the % by number is the same as the % by volume.
[0019] In an advantageous embodiment, the closed pores of the spheres according to the invention are not interconnected with each other. Thus, in this case, the spheres according to the invention contain several pores (at least two pores) not only closed towards the outside of the sphere but also not interconnected with each other. The porous sphere according to the invention is therefore advantageously not a hollow sphere. Each pore will thus comprise a void volume (in particular containing air) inaccessible to the formulation medium, in particular to polymers, oligomers and molecules having a molecular weight greater than 5000 g / mol. In an advantageous embodiment, the closed pores are spherical in shape.According to the invention, the term "spheres" or "spherical" means particles or pores whose shape has an aspect ratio or width / height ratio close to 1, advantageously between 0.9 and 1.1, more particularly between 0.95 and 1.05, in particular between 0.99 and 1.01, even more particularly around 1.
[0020] In another advantageous embodiment, the spheres according to the invention do not contain open pores and / or interconnected pores.
[0021] Advantageously, the size distribution of the closed pores of the spheres according to the invention is monodisperse or bimodal, advantageously monodisperse.
[0022] According to a preferred embodiment, the porous spheres with closed porosity according to the invention have an average diameter measured by scanning electron microscopy (SEM) ranging from 0.5 pm to 100 pm and / or an average porosity ranging from >0.10 to 0.80 and / or an average pore diameter, in particular closed pores, measured by scanning electron microscopy (SEM) ranging from 50 nm to 800 nm, advantageously from 50 nm to 500 nm.
[0023] According to another preferred embodiment, the porous spheres with closed porosity according to the invention have an average diameter measured by scanning electron microscopy (SEM) ranging from 1 pm to 100 pm and / or an average porosity ranging from >0.10 to 0.80 and / or an average pore diameter, in particular closed pores, measured by scanning electron microscopy (SEM) ranging from 50nm to 800nm, advantageously from 50nm to 500nm.
[0024] Advantageously, the porous spheres with closed porosity according to the invention have an average diameter measured by scanning electron microscopy (SEM) ranging from 0.5 μm to 100 μm and an average porosity ranging from >0.10 to 0.80 and an average pore diameter, in particular closed pores, measured by scanning electron microscopy (SEM) ranging from 50 nm to 800 nm. Particularly advantageously, the porous spheres with closed porosity according to the invention have an average diameter measured by scanning electron microscopy (SEM) ranging from 1 μm to 100 μm and an average porosity ranging from >0.10 to 0.80 and an average pore diameter, in particular closed pores, measured by scanning electron microscopy (SEM) ranging from 50 nm to 800 nm.
[0025] Preferably, the metal oxide of the porous spheres with closed porosity according to the invention is chosen from silicon, titanium, aluminum, zirconium, cerium, iron oxide, zinc oxide, indium oxide, tin oxide, chromium oxide, mixed metal oxide and combinations thereof, preferably silicon, titanium, aluminum and zinc oxide and combinations thereof, even more preferably silicon, titanium oxide and combinations thereof, particularly advantageously, silicon oxide.
[0026] In an advantageous embodiment, the porous spheres with closed porosity according to the invention comprise from 60% by weight to 99.9% by weight of metal oxide and from 0.1% by weight to 40% by weight of light absorbing agents, by total weight of the spheres, advantageously from 0.1% by weight to 40% by weight of carbon black.
[0027] Preferably, the porous spheres with closed porosity according to the invention have an average diameter measured by scanning electron microscopy (SEM) ranging from 1 μm to 100 μm and an average pore diameter measured by scanning electron microscopy (SEM) ranging from 50 nm to 800 nm.
[0028] Preferably, the porous spheres with closed porosity according to the invention have an average diameter measured by scanning electron microscopy (SEM) ranging from 1 μm to 75 μm and an average porosity ranging from 0.45 to 0.70, preferably from 0.5 to 0.65.
[0029] According to a particular embodiment of the invention, the porous spheres with closed porosity according to the invention have an average diameter measured by scanning electron microscopy (SEM) ranging from 2.5 pm to 8 pm, an average porosity ranging from 0.45 to 0.70 and an average pore diameter, in particular of closed pores, measured by scanning electron microscopy (SEM) ranging from 100 nm to 200 nm.
[0030] Advantageously, the use according to the invention is to reduce the visibility of unsightly manifestations of the skin, skin appendages and / or mucous membranes, in particular irregularities in the relief and / or texture of the skin, mucous membranes and / or skin appendages, and / or irregularities in the color of the skin and / or mucous membranes.
[0031] According to a particular embodiment of the invention, the porous spheres with closed porosity according to the invention are present in a cosmetic composition, at a concentration ranging from 1 x 103 at 10% by weight, preferably from 0.5% to 5% by weight relative to the total weight of the composition.
[0032] Advantageously, the use according to the invention is to improve the organoleptic properties of the cosmetic composition.
[0033] The present invention also relates to a cosmetic care method for improving the appearance and / or comfort of the skin, skin appendages, in particular the hair, and / or mucous membranes, comprising the topical application to at least one area of skin and / or skin appendages and / or mucous membranes of porous spheres with closed porosity comprising a metal oxide and / or a cosmetic composition comprising them.
[0034] In particular, porous spheres with closed porosity are as described above.
[0035] Advantageously, the cosmetic care method according to the invention is for reducing the visibility of unsightly manifestations of the skin, skin appendages and / or mucous membranes, in particular irregularities in the relief and / or texture of the skin, mucous membranes and / or skin appendages, and / or irregularities in the color of the skin and / or mucous membranes.
[0036] In an advantageous embodiment, the area of skin of the body and / or the cutaneous and / or mucous membrane appendage is chosen from the skin of the face, including the forehead, cheeks, nose, temples, the so-called "T" area (forehead, nose and chin), under the eyes, the peri-orbital area, in particular the dark circles, of the chin, scalp, neck, back, shoulders, arms, forearms, thorax, hands, hair, beard, eyelashes, eyebrows, bust, in particular the décolleté, stomach and / or armpits, legs, feet, hands, neck, thighs, hips, buttocks, waist, torso, lip contour, hair, hair and / or ocular, labial and / or buccal mucosa, preferably the skin of the face, hands, décolleté.
[0037] The present invention also relates to cosmetic compositions containing these porous spheres with closed porosity, in particular for the uses mentioned, and optionally a cosmetically acceptable excipient.
[0038] Advantageously, the cosmetic composition according to the invention is in the form of a serum, a lotion, a cream, a shampoo, a conditioner, an oil, a milk, an ointment, a paste, a mousse, an emulsion, a hydrogel, a shower gel, a mask, a lacquer, a spray, a wax, a powder, in particular makeup, or a stick.
[0039] Advantageously, the cosmetic composition according to the invention is in the form of a slightly gelled composition and / or comprises an oily phase, preferably it is of the oily composition or oil-in-water or water-in-oil emulsion or lotion type.
[0040] The present invention also relates to pharmaceutical compositions, in particular dermatological compositions, containing these porous spheres with closed porosity, and optionally a pharmaceutically acceptable excipient, in particular dermatologically acceptable.
[0041] The present invention also relates to a pharmaceutical composition according to the invention, preferably dermatological, for its use in improving the comfort of the skin, appendages and / or mucous membranes, in particular presenting a pathological condition, in particular manifested by a loss of homogeneity and / or a deregulation and / or an irregularity of the color, the complexion, the secretion of sebum and / or the relief, such as hyperpigmented, hypopigmented, hyperseborrheic, reactive, inflammatory, atopic skin, in particular skin affected by vitiligo, melanoma, couperose, telangiectasia, acne, rosacea, urticaria, psoriasis, herpes, impetigo, ecthyma, erysipelas, and / or presenting wounds and / or scars in particular acne, pimples, boils, varicose veins, melasma, folliculitis, abscesses, any combination thereof.
[0042] The present invention also relates to the use of the porous spheres with closed porosity according to the invention for the preparation of a pharmaceutical composition according to the invention, preferably dermatological, intended to improve the comfort of the skin, appendages and / or mucous membranes, in particular presenting a pathological condition, in particular manifested by a loss of homogeneity and / or a deregulation and / or an irregularity of the color, the complexion, the secretion of sebum and / or the relief, such as hyperpigmented, hypopigmented, hyperseborrheic, reactive, inflammatory, atopic skin, in particular skin affected by vitiligo, melanoma, couperose, telangiectasia, acne, rosacea, urticaria, psoriasis, herpes, impetigo, ecthyma, erysipelas, and / or presenting wounds and / or scars in particular acne, pimples, boils, varicose veins, melasma, folliculitis, abscesses, any combination thereof.Such cosmetic or pharmaceutical compositions, preferably dermatological, advantageously comprise the spheres at a concentration ranging from 1 x 10'. 3 at 10% by weight, preferably from 0.5% to 5% by weight relative to the total weight of the composition.
[0043] The use according to the invention is preferably cosmetic, and by topical application to at least one area concerned or part of healthy skin, healthy mucosa and / or healthy cutaneous appendages, preferably hair, preferably in humans.
[0044] For the purposes of the present invention, the term "cosmetic use" means a non-therapeutic, non-pharmaceutical use of the spheres according to the invention, preferably on healthy skin, in particular a healthy scalp, and / or healthy skin appendages, in particular healthy hair, and / or healthy mucous membranes.
[0045] For the purposes of the present invention, the term "part of skin, preferably of the scalp, and / or of the mucous membrane and / or of the cutaneous appendages, and / or area of skin, preferably of the scalp, and / or of the mucous membrane and / or of the cutaneous appendages referred to as "healthy", is understood to mean a part of the skin, preferably of the scalp, and / or of the mucous membrane and / or of the cutaneous appendages, and / or an area of skin, preferably of the scalp, and / or of the mucous membrane and / or of the cutaneous appendages qualified as non-pathological by a dermatologist, that is to say which does not present any infection, inflammation, in particular in the form of sunburn, disease or skin conditions such as folliculitis, candidiasis, psoriasis, ichthyosis, eczema, acne, impetigo, boils, abscesses, herpes, ecthyma, erysipelas or dermatitis, varicose veins, rosacea or telangiectasia, pathologies or wounds or burns, sunburn or injuries or does not suffer from solar elastosis, which is not reactive or atopic skin.In particular, it is a part of skin and / or mucous membrane made up of cells described as "normal" by a doctor, that is to say, non-cancerous cells.
[0046] The term "topical application" or "topical application", as used herein, means applying the spheres according to the present invention, optionally in the form of an active ingredient and / or composition, to the surface of the skin including the scalp, skin appendages, in particular hair, and / or mucous membranes, in particular by direct application or by vaporization.
[0047] By "improving the appearance" we mean diminishing or reducing the visibility of unsightly manifestations, in particular masking or hiding them, preferably those present on the face, in particular by filling and / or optical effect.
[0048] According to the present invention, "unsightly manifestations" are unsightly irregularities in the relief and / or texture of the skin, mucous membranes and / or cutaneous appendages and / or irregularities in the color of the skin, mucous membranes and / or cutaneous appendages.
[0049] According to the present invention, the unsightly irregularities in the relief and texture of the skin are wrinkles and fine lines, in particular lion's wrinkles and crow's feet, roughness, blackheads, dilated pores, rough appearance, marks and scars, in particular those due to injuries, acne, spots, burns and / or stretch marks.
[0050] According to the present invention, the irregularities in skin color are pigment spots, in particular white or dark spots, in particular age spots or hyperpigmented or depigmented spots, pregnancy mask, moles, melanomas, freckles, redness, but also loss of radiance of the complexion, dull complexion, dark circles and bags, rosacea, couperose.
[0051] According to a preferential method, the unsightly manifestations are selected from wrinkles, fine lines, blackheads, visible pores, loss of radiance of the complexion, dull complexion, dark circles, bags, pigment spots and any mixture of these.
[0052] Unsightly signs of skin appendages, especially hair, include dullness and brittleness. For hair, these signs also include brittleness, brittleness, damage and / or difficulty in shaping, particularly for hair, styling, and / or split ends.
[0053] Unsightly manifestations of the mucous membranes include a dull, cracked, withered and / or damaged appearance, as well as scales.
[0054] Generally, the improvement of unsightly manifestations can be visualized and evaluated by microscopy and / or by analysis of high-resolution photography, including measurement of the brightness of the area of skin, mucous membrane and / or cutaneous appendages.
[0055] The improvement of the complexion's radiance, known as "radiance" or "glow" in English, can be measured by an objective instrumental method. This in vivo measurement method consists of taking high-resolution photographs in a crossed polarized configuration of the volunteers' faces at 45° before and after application of the tested product. Based on these digital photographs, an image analysis makes it possible to extract and quantify specific parameters (for example: L*, a*, b*, C, h°) related to the color, radiance, homogeneity, and texture of the skin.
[0056] Similarly, the so-called "gloss" shine can in particular be measured according to this method on the basis of high-resolution photographs in crossed polarized and parallel polarized configuration of the face of the volunteers taken at 45° before and after application of the tested product. On the basis of these digital photographs, an image analysis makes it possible to extract and quantify specific parameters related to shine such as specular shine and contrast shine. For the purposes of the present invention, "reducing the visibility of skin pores" means masking skin pores, in particular by filling and / or by optical effect.
[0057] The visibility of skin pores can be demonstrated in vivo by an objective instrumental method (image analysis) which makes it possible to extract and quantify specific parameters from high-resolution photographs in cross-polarized configuration of the face of volunteers before and after application of a composition comprising the spheres according to the invention. The density of skin pores can also be measured in vivo by imaging, in particular by the fringe projection technique, by measuring the so-called curvature parameter.
[0058] In a preferred embodiment of the invention, the spheres according to the invention are in an effective amount to reduce the visibility of the pores of the skin by at least 10%, preferably by at least 20%, after application of a cream comprising the spheres according to the invention, still preferably prepared under the conditions described in one of examples 1 to 7, preferably formulated in the form of a cosmetic composition such as that described in examples 9 and 10.
[0059] The term "mucosa" means the ocular mucosa, the vaginal mucosa, the urogenital mucosa, the anal mucosa, the nasal mucosa and / or the buccal, labial and / or gingival mucosa, preferably the ocular and / or buccal and / or labial and / or gingival mucosa.
[0060] In the context of the present invention, the term "improving comfort" means increasing the organoleptic properties, in particular the feel and ease of spreading of the composition, in particular by a soft, silky, light, and smooth feel, but also giving a feeling of flexibility to the area to which the composition containing the spheres has been applied. The organoleptic properties and in particular the feel of a composition can be evaluated according to conventional methods in the field, in particular by evaluation by people trained to carry out sensory tests on the skin. For a better evaluation, the measurement is carried out by comparison with a placebo, i.e. the same composition which does not contain the spheres according to the invention. This evaluation is preferably carried out on an emulsion.
[0061] Advantageously, the improvement in comfort is analyzed by sensory evaluation of an emulsion as described in Example 9. A panel of trained individuals evaluates the compositions by applying a defined amount of composition to their forearm. According to a defined procedure, the composition is spread on the skin and its specific characteristics are evaluated, such as, for example, its absorption, softness, and appearance compared to a placebo composition. A value from -1 to +1 is given. For example, for the sensation of lightness, the tested composition can be evaluated +1 to indicate that it is much lighter than the reference composition known as the placebo or slightly less light than the placebo composition with the value -0.5.
[0062] If two compositions provide the same perception, then people indicate the value 0 for the evaluated parameter. Such evaluations are carried out in the same way for the tested composition and the reference composition, under the same climatic conditions and blindly. A statistical analysis then makes it possible to assess the significance and the differences in the evaluation results.
[0063] According to the invention, the term "cutaneous appendages" means hair, eyelashes, eyebrows, beard, moustache and / or nails, preferably hair.
[0064] Advantageously, the use according to the present invention makes it possible to improve the appearance of the skin by improving the radiance of the complexion, making it more uniform, shiny, providing a healthy, fresh, luminous effect, in particular by hiding unsightly manifestations of texture, relief and / or color of the skin. According to another embodiment, the spheres according to the invention also make it possible to soften the skin and / or mucous membranes and / or cutaneous appendages which show signs of discomfort, in particular the skin and / or mucous membranes and / or cutaneous appendages which have been exposed to aggressive conditions of a mechanical nature such as shaving, rubbing, drying, wind, sun, and hair removal, and / or of a chemical nature such as hair treatments, in particular (de)coloring, perming and straightening, detergents, exfoliating treatments.
[0065] According to a particular embodiment, the use according to the present invention makes it possible to illuminate, to brighten the skin, the skin appendages, in particular the hair and / or the mucous membranes, to make them more uniform, to create a blur in particular called "soft-focus", to soften the features, to fill in irregular features and marks in particular as a filling agent in particular for wrinkles.
[0066] The spheres or microspheres according to the invention are porous metal oxide spheres with closed porosity. Such spheres are photonic beads, which means that they exhibit a degree of periodic color variations, in particular which have an impact on light waves including the perception of color, clarity, transparency, brightness.
[0067] The spheres according to the invention comprise a metal oxide and preferably have an average diameter measured by scanning electron microscopy (SEM) ranging from 0.5 pm to 100 pm and / or an average porosity ranging >0.10 to 0.80 and / or an average pore diameter, in particular closed pores, measured by scanning electron microscopy (SEM) ranging from 50 nm to 500 nm.
[0068] The microspheres or porous spheres with closed porosity according to the invention mainly contain the metal oxide. Advantageously, they consist essentially of the metal oxide. Preferably, they consist exclusively of metal oxide. Advantageously, the porous spheres with closed porosity according to the invention comprise between 60% and 99.9% of metal oxide, preferably at least 70%, more preferably at least 80%, more preferably at least 90%, more preferably 99.9% of metal oxide, by weight relative to the total weight of the spheres. Thus, in an advantageous embodiment, the porous spheres according to the invention contain at least 70% of metal oxide, by weight relative to the total weight of the spheres.
[0069] According to the invention, the metal oxides include transition metal oxides, metalloids and earth metals compatible with cosmetic and / or dermatological use, such as for example silica, titanium, alumina, zirconia, cerium, iron oxide, zinc oxide, indium oxide, tin oxide, chromium oxide, mixed metal oxide, combinations thereof. Preferably the metal oxide is chosen from the group consisting of SiO2, TiO2, ZnO and their mixtures, advantageously from the group consisting of SiO2, TiO2 and ZnO, more advantageously from the group consisting of SiO2, ZnO and their mixtures, even more advantageously from the group consisting of SiO2 and ZnO, in particular it is SiO2. In an advantageous embodiment, the metal oxides do not include TiO2 and / or a mixture of several metal oxides.
[0070] In a particular embodiment, the porous spheres with closed porosity according to the invention, in particular of which at least 90% of the pores are closed pores, have an average diameter measured by scanning electron microscopy (SEM) ranging from 1 μm to 100 μm and an average pore diameter measured by scanning electron microscopy (SEM) ranging from 50 nm to 800 nm and comprise at least 70% of metal oxide. In particular, these spheres do not contain TiO2 and / or are not used in combination with a UV filter and / or in a composition comprising it. In an advantageous embodiment, the porous spheres with closed porosity according to the invention may comprise, for example, from 60% by weight to 99.9% by weight of metal oxide and from 0.1% by weight to 40% by weight of light-absorbing agents, by total weight of the spheres.According to one embodiment of the invention, the porous spheres with closed porosity according to the invention contain 0.3%, preferably 0.5%, preferably at least 1%, still preferably at least 5% by weight of light-absorbing agents, relative to the total weight of the spheres.
[0071] According to an alternative and preferred embodiment, the porous spheres with closed porosity according to the invention do not contain a light absorber and / or the cosmetic composition which contains them does not contain a light absorber either. Indeed, light absorbers such as TiCh can present a certain toxicity. However, the inventors have surprisingly discovered that even without a light absorber, the microspheres or spheres according to the invention have an immediate anti-blue light filter effect.
[0072] Advantageously, the light-absorbing agent(s) are selected from the group consisting of organic and inorganic pigments, compatible with cosmetic and / or dermatological application, in particular on the skin, mucous membranes and / or skin appendages, more particularly it is carbon black.
[0073] According to an advantageous preferred embodiment, the porous spheres with closed porosity according to the invention have an average diameter measured by scanning electron microscopy (SEM) ranging from 0.5 μm to 100 μm, advantageously from 1 μm to 100 μm. In this case, they are microspheres. Thus, advantageously, they are not nanospheres in order to avoid their penetration into the deep layers of the skin and / or mucous membranes and to preferentially have a surface effect. The microspheres according to the invention therefore advantageously remain on the surface of the skin and / or mucous membranes and / or cutaneous appendages.
[0074] "Microscale" or "micro-" means a size ranging from about 0.5 pm to about 999 pm. "Nanoscale" or "nano-" means a size ranging from about 1 nm to about 999 nm.
[0075] More advantageously, the porous spheres with closed porosity according to the invention have an average diameter measured by scanning electron microscopy (SEM) ranging from 1 pm to 75 pm, preferably from 2 pm to 70 pm, preferably from 3 pm to 65 pm, from 4 pm to 60 pm, from 5 pm to 55 pm or from 5 pm to 50 pm, still preferably from 10 pm to 25 pm, for example an average diameter measured by scanning electron microscopy (SEM) chosen from 1 pm, 2 pm, 3 pm, 4 pm, 5 pm, 6 pm, 7 pm, 8 pm, 9 pm, 10 pm, 11 pm, 12 pm, 13 pm, 14 pm, 15 pm, 16 pm, 17 pm, 18 p.m., 7 p.m., 8 p.m., 9 p.m., 10 p.m., 11 p.m., 12 p.m., 8 p.m. 8 p.m., 1 p.m., 10 p.m., 11 p.m. or 30 p.m.
[0076] In an alternative embodiment, the porous spheres with closed porosity according to the invention have an average diameter measured by scanning electron microscopy (SEM) selected from 4.5 pm, 4.8 pm, 5.1 pm, 5.4 pm, 5.7 pm, 6.0 pm, 6.3 pm, 6.6 pm, 6.9 pm, 7.2 pm, 7.5 pm, 7.8 pm, 8.1 pm, 8.4 pm, 8.7 pm, 9.0 pm, 9.3 pm, 9.6 pm or 9.9 pm,
[0077] In an alternative embodiment, the porous spheres with closed porosity according to the invention have an average diameter measured by scanning electron microscopy (SEM) ranging from 1.3 pm to 10 pm, more particularly from 1.5 to 9.9 pm, even more particularly from 2.5 pm to 8 pm, for example an average diameter chosen from 1 pm, 2 pm, 2.6 pm, 2.9 pm, 3 pm, 4 pm, 5 pm, 6 pm, 6.7 pm, 7 pm, 8 pm, 9 pm, 10 pm. In a preferred embodiment of the invention, the average pore diameter, in particular of the closed pores, of the porous spheres with closed porosity according to the invention, measured by scanning electron microscopy (SEM), ranges from 50 nm to 800 nm, advantageously from 50 nm to 500 nm, advantageously from 80 nm to 250 nm, advantageously from 100 nm to 245 nm, in particular from 100 nm to 200 nm, more particularly from 145 nm to 180 nm, more particularly from 150 nm to 160 nm, even more particularly from 150 nm to 155 nm, for example chosen from: 50 nm, 55 nm, 60 nm, 65 nm, 70 nm, 75 nm, 80 nm, 85 nm,90 nm, 95 nm, 100 nm, 105 nm, HOnm, 115 nm, 120 nm, 125 nm, 130 nm, 135 nm, 140 nm, 145 nm, 150 nm, 153 nm, 155 nm, 160 nm, 165 nm, 170 nm, 175 nm, 180 nm, 185 nm, 190 nm, 191 nm, 192 nm, 193 nm, 194 nm, 195 nm, 196 nm, 197 nm, 198 nm, 199 nm, 200 nm, 201 nm, 202 nm, 203 nm, 204 nm, 205 nm, 206 nm, 207 nm, 208 nm, 209 nm, 210 nm, 211 nm, 212 nm, 213 nm, 214 nm, 215 nm, 216 nm, 217 nm, 218 nm, 219 nm, 220 nm, 225nm, 230 nm, 235 nm, 240 nm, 245 nm, 250 nm 260 nm, 280 nm, 300 nm, 320 nm, 340 nm, 360 nm, 380 nm, 400 nm, 420 nm,
[0078] 440 nm, 460 nm, 480 nm, 500 nm, 520 nm, 540 nm, 560 nm, 580 nm,
[0079] 600 nm, 620 nm, 640 nm, 660 nm, 680 nm, 700 nm, 720 nm, 740 nm,
[0080] 760 nm, 780 nm or 800 nm.
[0081] In an alternative embodiment, the porous spheres according to the invention have an average diameter measured by scanning electron microscopy (SEM) ranging from 1.3 pm to 10 pm, more particularly from 1.5 to 9.9 pm, even more particularly from 2.5 pm to 8 pm, for example an average diameter chosen from 1 pm, 2 pm, 2.6 pm, 2.9 pm, 3 pm, 4 pm, 5 pm, 6 pm, 6.7 pm, 7 pm, 8 pm, 9 pm, 10 pm; and an average porosity selected from 0.45, 0.47, 0.49, 0.50, 0.51, 0.53, 0.55, 0.57, 0.59, 0.61, 0.63, 0.65, 0.67, 0.69 or 0.70;and an average pore diameter measured by scanning electron microscopy (SEM) of 100 nm to 200 nm, more particularly of 145 nm to 180 nm, more particularly of 150 nm to 160 nm, even more particularly of 150 nm to 155 nm, for example chosen from: 100 nm, 105 nm, HOnm, 115 nm, 120 nm, 125 nm, 130 nm, 135 nm, 140 nm, 145 nm, 150 nm, 153 nm, 155 nm, 160 nm, 165 nm, 170 nm, 175 nm, 180 nm, 185 nm, 190 nm, 191 nm, 192 nm, 193nm, 194nm, 195nm, 196nm, 197nm, 198nm, 199nm or 200nm.;
[0082] In the porous sphere according to the invention, the average diameter of the spheres is significantly larger than the average diameter of the pores. For example, the average diameter of the spheres is generally at least 25 times, preferably at least 30 times, preferably at least 35 times, and even more preferably 4 times larger than the average diameter of the pores.
[0083] In some embodiments, the ratio of the average diameter of the spheres to the average diameter of the pores is at least 40 / 1, at least 50 / 1, at least 60 / 1, at least 70 / 1, at least 80 / 1, at least 90 / 1, at least 100 / 1, at least 110 / 1, at least 120 / 1, at least 130 / 1, at least
[0084] 140 / 1, at least 150 / 1, at least 160 / 1, at least 170 / 1, at least 180 / 1, at least 190 / 1, at least 200 / 1, at least 210 / 1, at least 220 / 1, at least 230 / 1, at least 240 / 1, at least 250 / 1, at least 260 / 1, at least
[0085] 270 / 1, at least 280 / 1, at least 290 / 1, at least 300 / 1, at least 310 / 1, at least 320 / 1, at least 330 / 1, at least 340 / 1 or at least 350 / 1.
[0086] In a preferred embodiment of the invention, the porous spheres with closed porosity according to the invention have an average porosity ranging from >0.10 to 0.80, in particular chosen from: 0.4, 0.41, 0.42, 0.43, 0.44, 0.45, 0.46, 0.47, 0.48, 0.49, 0.50, 0.51, 0.52, 0.53, 0.54, 0.55, 0.56, 0.57, 0.58, 0.59, 0.60, 0.61, 0.62, 0.63, 0.64, 0.65, 0.66, 0.67, 0.68, 0.69 or 0.70, preferably ranging from 0.45 to 0.70, preferably 0.50 to 0.65.
[0087] According to the invention, the size of the spheres and / or pores is a synonym for the diameter of the spheres and / or pores and is determined by scanning electron microscopy (SEM). The mean diameter of the spheres and / or pores (or mean size) is understood to mean the average of the diameter of the spheres and / or pores, which can be supplemented by measuring the standard deviation. It is obtained by analyzing 100 to 150 spheres and / or 50 to 70 pores of different spheres by scanning electron microscopy using analysis software, in particular ImageJ image software.
[0088] The average porosity of a sphere refers to the total pore volume, as a fraction of the volume of the entire sphere. Average porosity can also be referred to as the "volume fraction." It is a dimensionless quantity. It is calculated by the ratio between the volume of the unoccupied space (interior of the pores) and the total volume of the sphere. For example, a porous silica sphere according to the invention having an average diameter of 7.6 μm and containing closed pores with an average diameter of 165 nm has an average porosity of 0.8. The pore diameter is determined by the diameter D50 of the nanoparticle polymers that compose it. The larger the diameter D50 of the nanoparticle polymers that compose it, the larger the average pore diameter. Similarly, the concentration of nanoparticles is adjusted according to the average diameter of spheres that is desired. The higher the concentration of nanoparticles, the larger the size of the spheres.
[0089] Mercury porosimetry analysis is used to characterize the porosity of spheres. Mercury porosimetry involves applying controlled pressure to the sample to be measured while immersed in mercury. External pressure is applied so that the mercury penetrates the pores / holes in the material. The amount of pressure required is inversely proportional to the pore / hole size. The mercury porosimeter then provides volume and pore size distributions. The mercury porosimeter generates volume and pore size distributions from the pressure data versus the intrusion data generated by the instrument using the Washburn equation.
[0090] In an advantageous embodiment, the spheres according to the invention do not contain and / or are not used in combination with an anti-blue light filter and / or an anti-UV filter and / or a sunscreen and / or in a cosmetic composition which contains them. Thus, the spheres according to the invention are not used as a booster for anti-blue light filters and / or to increase the SPF (sun protection factor) of a sunscreen composition.
[0091] In an advantageous embodiment, the porous spheres according to the invention do not comprise a coating layer on their surface containing a hydrophobic compound. In a particularly advantageous embodiment, the porous spheres according to the invention do not comprise a coating layer on their surface.
[0092] According to a particular embodiment of the invention, the porous spheres according to the invention do not comprise a coating layer on their surface containing a polyorganosiloxane, in particular a silicone compound.
[0093] Porous spheres comprising a metal oxide can be prepared using a mold made of polymers commonly referred to as a "polymer template" or sacrificial polymer model. Such porous spheres exhibit a color observable by the human eye, i.e., a color observable to the naked eye, or may appear white.
[0094] “A color observable to the naked eye” means a color that is perceived by a majority of people. This can be for any sample of spheres according to the invention distributed over a given surface, for example, over 1 cm 2 , 2 cm 2 , 3 cm 2 , 4 cm 2 , 5 cm 2 or 6 cm 2 , 7 cm 2 , 8 cm 2 , 9 cm 2, 10 cm 2 , 11 cm 2 , 12 cm 2 , 13 cm 2 , 14 cm 2 or 15 cm 2 . It can also mean that it is observable by the CIE 1931 2° standard observation model and / or by the CIE 1964 10° standard observation model. The observation background of the color can be of different kinds for example white, black, or anything intermediate between black and white.
[0095] According to one embodiment, the spheres according to the invention are prepared by the process having the following 3 steps:
[0096] Step 1: Liquid droplets are generated from a dispersion of particles, said dispersion comprising first particles (a) comprising a polymer and second particles (b) comprising a metal oxide or a metal oxide precursor. This dispersion of particles is advantageously an aqueous dispersion at a pH in the range 8-10, in particular a colloidal dispersion.
[0097] The droplets are advantageously obtained using a microfluidic device. Microfluidic devices are, for example, narrow channel devices having a microscale junction adapted to produce uniform droplets, the channels being connected to a collection reservoir. The microfluidic devices contain, for example, a junction having a channel width ranging from 10 μm to about 100 μm. These devices are, for example, made of polydimethylsiloxane (PDMS) and can be prepared, for example, by soft lithography. An emulsion of the aqueous dispersion of particles in an oily continuous phase can be prepared inside the device by pumping the aqueous dispersed phase and the oily continuous phase at a defined ratio, thereby forming an emulsion by mixing the two phases.Alternatively, an oil-in-water emulsion may be used if the particle dispersion is an oily dispersion and the continuous phase is an aqueous phase. The continuous oily phase comprises, for example, an organic solvent, a silicone oil, or a fluorinated oil. According to the invention, the term "oil" denotes an organic phase (e.g., an organic solvent) that is immiscible with water. Organic solvents include hydrocarbons, such as heptane, hexane, toluene, xylene, and alcohols, such as methanol, ethanol, propanol, etc.
[0098] Step 1) may also be carried out not from a dispersion comprising first particles (a) comprising a polymer and second particles (b) comprising a metal oxide or a metal oxide precursor, but from a dispersion comprising particles (a) comprising a polymer in a sol-gel matrix of metal oxide or its precursor (b).
[0099] Step 2: The droplets are dried so as to remove the solvent in order to provide dry spheres in the form of a matrix of the second particles (b) or the sol-gel matrix (b) within which there are first particles (a). There is in fact a self-assembly between the first particles (a) and the second particles (b) or the sol-gel matrix (b) to form spheres having a matrix based on metal oxide or metal oxide precursor in which the polymer particles (a) are embedded. The spheres obtained are recovered, for example by filtration or centrifugation.
[0100] Drying is carried out using conventional techniques, for example by microwave irradiation, in a thermal oven, under vacuum, in the presence of a dehydrating / absorbing agent or a mixture of these techniques.
[0101] Steps 1) and 2) may be performed simultaneously by atomization. In some embodiments of the spray drying techniques, the dispersion of particles (first particles (a) comprising a polymer and second particles (b) comprising a metal oxide or a metal oxide precursor or first particles (a) comprising a polymer in a sol-gel matrix of metal oxide or its precursor (b)) is fed (e.g. pumped) into an atomization nozzle with a compressed gas inlet. The feed is pumped through the atomization nozzle to form liquid droplets. The droplets are surrounded by a preheated gas in the evaporation chamber, resulting in the evaporation of the solvent to produce solid particles in the form of spheres (matrix of the second particles (b) or the sol-gel matrix (b) within which there are first particles (a)).The dried Tl particles are carried by the drying gas through the cyclone and deposited in the collection chamber. Usable gases include nitrogen and / or air.
[0102] In one embodiment of the spray drying method, the feed liquid contains an aqueous or oily phase in which the particles (first particles (a) comprising a polymer and second particles (b) comprising a metal oxide or a metal oxide precursor or a sol-gel matrix of a metal oxide or its precursor (b)) are dispersed. Spray drying techniques include inkjet spray drying methods. Vibrating nozzles are commercially available from BÜCHI and comprise, for example, a syringe pump and a pulsation unit.
[0103] Step 3: The dry spheres are calcined and optionally sintered. During this step, the metal oxide spheres or the sol-gel matrix densify and form a stable matrix around the polymer particles (a) and the polymer particles are removed by calcination (at a temperature ranging from 200-1200°C for a period ranging from 0.1 hour to 10 hours, advantageously at a temperature ranging from 300-800°C for a period ranging from 1 to 8 hours).
[0104] The calcination is carried out according to one embodiment at temperatures ranging from 200°C to 1200°C. According to one embodiment, the calcination temperature is at least 200°C, preferably at least 500°C, more preferably at least 1000°C. Alternatively, the calcination temperature ranges from 300°C to 800°C. The calcination is carried out for a suitable duration, for example ranging from 0.1 hour to about 10 hours, preferably from 1 hour to 8 hours. In certain embodiments, the calcination is carried out for at least 0.1 hour, for at least 1 hour, for at least 5 hours or for at least 8 hours. The first polymer particles (a) therefore served as templates for the formation of the pores in the spheres according to the invention. The polymer particles (a) define an interstitial space.Calcination results in polymer shrinkage, providing a metal oxide sphere with high porosity or large interstitial volume (inverse structure). Porous metal oxide spheres are advantageously sintered, leading to a continuous, consolidated, thermally and mechanically stable solid structure.
[0105] The first polymer particles (a) usable in the process as a template are nanoparticles. They are also spherical, monodisperse and have a diameter D5o measured by dynamic light scattering (DLS) measurement or by scanning electron microscopy (SEM), preferably by dynamic light scattering (DLS) measurement ranging from 50 nm to about 800 nm, advantageously from 50 nm to 500 nm.
[0106] We don't hear diameter D 50 , the median diameter, meaning that half the population is below and the other half is above.
[0107] Advantageously, the polymer nanoparticles (a) have a diameter D5o measured by dynamic light scattering measurement
[0108] (DLS) of 50nm, 75nm, 100nm, 130nm, 160nm, 190nm, 210nm, 240nm, 270nm, 300nm, 330nm, 360nm, 390nm, 410nm, 440nm, 470nm, 500nm, 530nm, 560nm, 590nm, 620nm, 650nm, 680nm, 710nm, 740nm, 770nm or 800nm.
[0109] Preferably, the polymer is selected from the group consisting of poly(meth)acrylic acid, poly(meth)acrylates, polystyrenes, polyacrylamides, polyvinyl alcohol, polyvinyl acetate, polyesters, polyurethanes, polyethylene, polypropylene, polylactic acid, polyacrylonitrile, polyvinyl ethers, as well as their derivatives and salts, their copolymers and their combinations.For example, the polymer is selected from the group consisting of polymethyl methacrylate, polyethyl methacrylate, poly(n-butyl methacrylate), polystyrene, poly(chloro-styrene), poly(alpha-methylstyrene), poly(N-methylolacrylamide) styrene / methyl methacrylate copolymer, polyalkylated acrylate, polyhydroxyl acrylate, polyamino acrylate, polycyanoacrylate, polyfluorinated acrylate, poly(N-methylolacrylamide), polyacrylic acid, polymethacrylic acid, methyl methacrylate / ethyl acrylate / acrylic acid copolymer, styrene / methyl methacrylate / acrylic acid copolymer, polyvinyl acetate, polyvinylpyrrolidone, polyvinylcaprolactone, polyvinylcaprolactam, a copolymer of methyl methacrylate and methyl chloride, [2-(methacryloyloxy)ethyl]trimethylammonium, as well as their derivatives and salts, their copolymers and their combinations.Preferably, the polymer is chosen from the group consisting of polystyrenes, for example a copolymer of polystyrene / acrylic acid, polystyrene / poly(ethylene glycol) methacrylate or polystyrene / styrene sulfonate.
[0110] The spheres according to the invention may contain uniform pore diameters, due to the use of spherical and monodisperse polymer particles (a).
[0111] The second particles (b) or the sol-gel matrix comprising a metal oxide or a metal oxide precursor which can be used in the method according to the invention can be obtained by the sol-gel technique.
[0112] Advantageously, the second particles (b) usable in the process are nanoparticles. They have, for example, a diameter D 50measured by scanning electron microscopy (SEM) or dynamic light scattering (DLS) measurement, preferably by scanning electron microscopy (SEM) ranging from 1 nm to approximately 120 nm.
[0113] Advantageously, the nanoparticles comprising a metal oxide or a metal oxide precursor (b) have a diameter D 50 measured by scanning electron microscopy (SEM) of 1 nm, 5 nm, 10 nm, 15 nm, 20 nm, 25 nm, 30 nm, 35 nm, 40 nm, 45 nm, 50 nm, 55 nm, 60 nm, 65 nm, 70 nm, 75 nm, 80 nm, 85 nm, 90 nm, 95 nm, 100 nm, 105 nm, 110 nm, 115 nm, or 120 nm.
[0114] These nanoparticles (b) can be spherical or non-spherical.
[0115] The second particles (b) or the sol-gel matrix may be made of metal oxide or a metal oxide precursor, including silica, titanium, alumina, zirconia, cerium, iron oxides, zinc oxide, indium oxide, tin oxide, chromium oxide, and combinations thereof; tetraethyl orthosilicate (TEOS) or tetramethyl orthosilicate (TMOS) as a silica oxide precursor, titanium propoxide as a titanium oxide precursor, or zirconium acetate as a zirconium oxide precursor.
[0116] In an advantageous embodiment, the first polymer nanospheres (a) have a positively charged surface and the second metal oxide particles or their precursor (b) or the sol-gel matrix (b) have a negatively charged surface.
[0117] In another advantageous embodiment, the first polymer nanospheres (a) have a negatively charged surface and the second metal oxide particles or their precursor (b) or the sol-gel matrix (b) have a positively charged surface.
[0118] It is the difference in charge on the surface that will cause the self-assembly of the particles between themselves or of the particles with the sol-gel matrix during the sphere manufacturing process.
[0119] The weight ratio (weight / weight) of nanoparticles or sol-gel matrix of metal oxide or precursor / polymer nanoparticles ranges for example from 1 / 10 to 10 / 1 or from 1 / 3 to 3 / 2. Advantageously this ratio is: 1 / 10, 2 / 10, 3 / 10, 4 / 10, 5 / 10 6 / 10, 7 / 10, 8 / 10, 9 / 10, 10 / 9, 10 / 8, 10 / 7, 10 / 6, 10 / 5, 10 / 4, 10 / 3, 10 / 2, or 10 / 1. In particular it is 1 / 3, 2 / 3, 1 / 1, or 3 / 2. Drying the polymer / metal oxide droplets followed by removal of the polymer in the process according to the invention makes it possible to obtain spheres having uniform cavities (pores). In general, in the described processes, each droplet forms a single microsphere or sphere. The pore diameters are dependent on the size of the polymer particles (a).A shrinkage or compaction phenomenon may occur during polymer shrinkage, producing pore sizes slightly smaller than the initial polymer particle size, for example, ranging from 10% to 40% smaller than the initial polymer particle size. The pore diameter is as uniform as the shape and size of the polymer particles were (a).
[0120] In some embodiments, the porous sphere has a solid center or core and porosity toward the outer surface of the sphere.
[0121] In other, rarer embodiments, the porous spheres have an empty center with porosity increasing toward the interior of the spheres.
[0122] In some embodiments, there is thus a gradient of porosity towards the center or towards the outside of the sphere but more frequently, the spheres have a homogeneous distribution of porosity within the sphere.
[0123] In other preferred embodiments of the invention, the porosity is distributed uniformly throughout the volume of the spheres.
[0124] The templates of monodisperse polymer spheres (a) can result in metal oxide spheres with similar pore diameters, once the polymer is removed.
[0125] The templates of the polymer spheres (a) of two different sizes can result in metal oxide spheres having pores of two different diameters, once the polymer is removed.
[0126] Without being bound by theory, it is believed that most spheres exhibit a saturated color with reduced light scattering when the porosity and / or diameter of the spheres and / or the diameter of the pores are within certain ranges. These color properties are particularly important and can be adjusted depending on the desired light scattering intensity on the skin, skin appendages and / or mucous membranes. In some embodiments, it is preferable to have white spheres, in other embodiments it is preferable to have transparent spheres.
[0127] Preferably, most of the porous spheres have a structural color observable to the naked eye, in particular at a wavelength in the range 380nm - 800nm. One or more so-called light-absorbing agents may also be present in the spheres, thus providing a more saturated observable color. Such absorbing agents are for example added during the physical mixing of the spheres or are included in the droplets before drying. Thus, for example in this case the spheres according to the invention have no observable color without a light-absorbing agent and have an observable color when a light-absorbing agent is added.
[0128] The spheres then have the advantage of being able to be used as a dyeing agent in cosmetic and / or dermatological compositions. The porous spheres according to the present invention may have an angle-dependent or non-angle-dependent color. An “angle-dependent color” is understood to mean an observed color that depends on the angle of the incident light or the angle between the observer and the observed color area. An angle-independent color means that the observed color does not substantively depend on the angle of the incident light or the angle between the observer and the observed color area. Spheres having an angle-dependent color can be obtained in particular by using monodisperse polymer nanospheres (a).They can also be obtained when the drying step of the liquid droplets to provide the template for the polymer spheres is carried out gently, thus allowing the polymer nanospheres to order themselves.
[0129] Spheres with angle-independent color can be obtained when the liquid droplet drying step is performed rapidly, not allowing the polymer nanospheres to order, or when two sizes of polymer spheres (a) are used in the process (whether these polymer spheres (a) are of monodisperse or polydisperse bimodal distribution).
[0130] The angle dependence of color is independent of the polydispersity or shape of the metal oxide particles (b).
[0131] Advantageously, the porous spheres according to the invention are themselves also monodisperse.
[0132] "Most spheres" means the population of spheres. This may be an amount of > 0.1 mg, > 0.2 mg, > 0.3 mg, > 0.4 mg, > 0.5 mg, > 0.7 mg, > 1.0 mg, > 2.5 mg, > 5.0 mg, > 10.0 mg, or > 25.0 mg. Most spheres may be free of other compounds.
[0133] For the population of porous spheres or polymer nanospheres or pores, the term "monodisperse" means particles or pores that have a homogeneous shape and a homogeneous diameter. The population of spheres and / or pores is thus said to be monodisperse when 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% of the number of particles or pores have a diameter of ± 7%, ± 6%, ± 5%, ± 4%, ± 3%, ± 2% or ± 1% relative to the average diameter of the population of spheres and / or pores or diameter D 50 of polymer nanospheres, these diameters being measured by scanning electron microscopy (SEM).
[0134] Removal of the monodisperse population of polymer nanospheres (a) provided metal oxide spheres having a population of pores with an average diameter.
[0135] Thus the spheres according to the invention comprising a metal oxide are prepared by a method comprising the following steps: - Forming a liquid dispersion of polymer nanospheres and nanoparticles of a metal oxide or its precursor or a sol-gel matrix;
[0136] - Form liquid droplets from the dispersion;
[0137] - Drying the liquid droplets of the spheres comprising the polymer nanospheres and the nanoparticles of a metal oxide or its precursor or the sol-gel matrix;
[0138] - Removing the polymer nanospheres from the model spheres to provide the porous metal oxide spheres according to the invention.
[0139] In an advantageous embodiment, the liquid droplets are aqueous. In an alternative, the liquid droplets are oily.
[0140] According to a preferred embodiment, the method comprises a continuous phase and mixing the liquid dispersion with this continuous phase to form an emulsion containing the dispersed liquid dispersion droplets. According to a particular embodiment, the continuous phase is oily and the mixing is carried out between the continuous oily phase and the aqueous liquid dispersion to form a water-in-oil emulsion containing aqueous droplets.
[0141] In an alternative embodiment, the continuous phase is aqueous and mixing is carried out between the continuous aqueous phase and the oily liquid dispersion to form an oil-in-water emulsion containing lipid droplets.
[0142] In an advantageous embodiment, the method comprises the subsequent steps of collecting the droplets, drying the droplets and removing the polymer nanospheres from the sphere template.
[0143] According to the present invention, the porous spheres according to the invention are used alone, in particular in powder form (100%), or in composition, in particular cosmetic, at a concentration ranging from 1 x 10 3 at 100% by weight, and advantageously ranging from lxlO -2 at 95%, preferably ranging from 0.01% to 80%, more preferably from 0.05% up to 50%, more preferably from 0.1% up to 30%, more preferably up to 20%, more preferably up to 10%, and more preferably from 0.5% to 5% by weight relative to the total weight of the composition.
[0144] The porous spheres according to the invention can be used alone, in particular in the form of a cosmetic active ingredient or in a composition intended to be in contact with the skin, the appendages and / or the cutaneous mucous membranes, such as for example a cosmetic composition, preferably intended for topical application.
[0145] The active ingredient and / or the cosmetic compositions containing the porous spheres according to the invention are preferably intended for the care and / or cosmetic treatment of the skin and / or mucous membranes, including the scalp as well as the cutaneous appendages, preferably the hair.
[0146] In another embodiment, the spheres according to the invention can be incorporated into a cosmetic composition further comprising at least one cosmetically acceptable excipient.
[0147] For the purposes of the present invention, the term “cosmetically acceptable” excipient means a topically acceptable compound and / or solvent, i.e. one which does not induce an allergic response on contact with the skin, including the human scalp, and skin appendages, which is non-toxic, non-unstable, or their equivalents, undue.
[0148] The cosmetic composition according to the invention can be presented in all the galenic forms conventionally used for topical application to the skin and / or mucous membranes, including the scalp, and cutaneous appendages, such as liquid or solid forms or even in the form of liquid under pressure.They may in particular be formulated in the form of an aqueous or oily solution, in particular a lotion, a cream or an aqueous gel or an oily gel, in particular in a pot or tube, in particular a shower gel, a shampoo, a conditioner, a milk, an oil, an emulsion, a hydrogel, a microemulsion or a nanoemulsion, in particular oil-in-water or water-in-oil or multiple or silicone, a serum, a lotion, in particular in a glass or plastic bottle or in a dosing bottle or in an aerosol or spray, an ampoule, a liquid or solid soap, a paste, an ointment, a mousse, a mask, a lacquer, a patch, an anhydrous product, preferably liquid, pasty or solid, for example in the form of a stick, in particular in stick form or in powder form, preferably a cream, a serum or a lotion.
[0149] It may also be a makeup product or a makeup removal product. In particular, the cosmetic composition is chosen from the group consisting of a serum, a lotion, a cream, a shampoo, a conditioner, an oil, a milk, an ointment, a paste, a mousse, an emulsion, a hydrogel, a shower gel, a mask, a lacquer, a spray, a wax, even more preferably it is a cream, a serum or a lotion. It may also be a powder, in particular a makeup powder, a stick foundation, compositions for beard care, after shaving and / or hair removal. According to an advantageous embodiment, the cosmetic composition according to the invention is at least slightly gelled and / or comprises an oily phase, preferably of the oily composition or oil-in-water or water-in-oil emulsion or lotion type.
[0150] The compositions according to the invention may contain any suitable solvent and / or any suitable vehicle and / or any suitable excipient, optionally in combination with other compounds of interest.
[0151] Therefore, for these compositions, the excipient contains, for example, at least one compound chosen from the group consisting of preservatives, emollients, emulsifiers, surfactants, moisturizers, thickeners, conditioners, matting agents, stabilizers, antioxidants, texturizing agents, glossing agents, film-forming agents, solubilizers, pigments, colorants, perfumes and sunscreens. These excipients are preferably chosen from the group consisting of amino acids and their derivatives, polyglycerols, esters, cellulose polymers and derivatives, lanolin derivatives, phospholipids, lactoferrins, lactoperoxidases, sucrose-based stabilizers, vitamins E and its derivatives, natural and synthetic waxes, vegetable oils, triglycerides, unsaponifiables, phytosterols, vegetable esters, silicones and its derivatives, protein hydrolysates,Jojoba oil and its derivatives, lipo / water-soluble esters, betaines, aminoxides, plant extracts, sucrose esters, titanium dioxides, glycines, and parabens, and more preferably from the group consisting of butylene glycol, steareth-2, steareth-21, glycol-15 stearyl ether, cetearyl alcohol, phenoxyethanol, methylparaben, ethylparaben, propylparaben, butylparaben, butylene glycol, natural tocopherols, glycerin, dihydroxycetyl sodium phosphate, isopropyl hydroxycetyl ether, glycol stearate, triisononanoin, octyl cocoate, polyacrylamide, isoparaffin, laureth-7, a carbomer, propylene glycol, glycerol, bisabolol, dimethicone, sodium hydroxide, PEG 30-dipolyhydroxysterate, capric / caprylic triglycerides, cetearyl octanoate, dibutyl adipate, grape seed oil, jojoba oil, magnesium sulfate, EDTA, cyclomethicone,xanthan gum, citric acid, sodium lauryl sulfate, mineral waxes and oils, isostearyl isostearate, propylene glycol dipelargonate, propylene glycol isostearate, PEG 8, Beeswax, hydrogenated palm oil glycerides, hydrogenated palm oil glycerides, lanolin oil, sesame oil, cetyl lactate, lanolin alcohol, castor oil, titanium dioxide, lactose, sucrose, low density polyethylene, isotonic saline solution. Many cosmetically active ingredients are known to those skilled in the art to improve the appearance of the skin. Those skilled in the art know how to formulate cosmetic or dermatological compositions to achieve the best effects. Furthermore, the compounds described in the present invention may have a synergistic effect when combined with each other. These combinations are also covered by the present invention. The CTFA Cosmetic Ingredient Handbook,Second Edition (1992) describes various cosmetic and pharmaceutical ingredients commonly used in the cosmetic and pharmaceutical industry, which are particularly suitable for topical use. Examples of these classes of ingredients include, but are not limited to, the following compounds: abrasive, absorbents, compounds for aesthetic purposes such as perfumes, pigments, colorants, essential oils, astringents, anti-acne agents, anti-flocculating agents, antifoaming agents, antimicrobial agents (e.g., iodopropyl butylcarbamate), antioxidants, binders, biological additives, buffering agents, bulking agents, chelating agents, additives, biocidal agents, denaturants, thickeners, and vitamins, and derivatives or equivalents thereof, film-forming materials, polymers, opacifying agents, pH adjusters, reducing agents,depigmenting or lightening agents (e.g. hydroquinone, kojic acid, ascorbic acid, magnesium ascorbyl phosphate, ascorbyl glucosamine), conditioning agents (e.g. humectants).,
[0152] In a particularly advantageous manner, the spheres according to the invention can be used, optionally in a cosmetic or pharmaceutical composition, preferably dermatological, as the sole agent improving the appearance, in particular the unsightly manifestations and / or the comfort of the skin, the appendages and / or the mucous membranes, or in combination with other active agents having the same properties or complementary and conventional properties in cosmetic or dermatological compositions such as for example those chosen from:
[0153] - moisturizing agents: one or more hydration-promoting agents such as a polysaccharide extracted from Cassia angustifoüa seeds marketed under the name Hyalurosmooth™ by the applicant, or an agent chosen from one of the combinations containing pullulan, sodium hyaluronate and sodium alginate marketed under the name PatcH20™ by the applicant or one or more of the compounds of the natural moisturizing factor (Natural Moisturizing Factor) or a natural honey extract marketed by the applicant under the name Melhydran™ and / or a compound from the glucosyl glyceride family, in particular hexosyl glyceride, an extract of Litchi chinensis pericarp under the name Litchiderm™ by the applicant;
[0154] - an agent stimulating the synthesis of fibronectin, in particular a corn extract, such an extract being marketed in particular by the applicant under the name DelinerTM;
[0155] - an agent for protecting the fibroblast growth factor (FGF2) of the extracellular matrix against its degradation and / or denaturation, in particular an extract of Hibiscus Abeimoscus as described in the patent application in the name of the applicant filed under number FR0654316 and / or an agent for stimulating the growth of fibroblasts, for example a fermented soybean extract containing peptides, known under the name PhytokineTM marketed by the applicant and also described in patent application EPI 119344 B1 (Laboratoires Expanscience), and preferably a combination of these two extracts;
[0156] - an agent stimulating the synthesis of laminin, in particular a malt extract modified by biotechnology, such an extract being notably marketed by the applicant under the name Basaline™; and an agent stimulating the synthesis of lipids such as a potato extract (solarium tuberosum) modified by biotechnology marketed by the applicant under the name Lipidessence™;
[0157] - an agent stimulating the expression and / or activity of Hyaluronan synthase 2 (HAS2) such as the plant extracts described in patent application FR2 893 252 A1 and in particular an aqueous extract of Galanga (Alpinia galanga marketed under the name Hyalufix™ by the applicant;
[0158] - an agent stimulating the synthesis of lysyl oxidase like (LOXL) such as those described in patent application FR2855968, and in particular a dill extract marketed under the name Lys'lastine™ by the applicant;
[0159] - one or more anti-pollution agents such as an extract of Argania spinosa leaves marketed under the name Arganyl™ by the applicant or an extract of Moringa oleifera seeds marketed under the name Purisoft™ by the applicant or an extract of Eperua falcata root marketed under the name Eperuline™ by the applicant;
[0160] - an agent stimulating the synthesis of intracellular ATP, in particular an extract of the algae Laminaria digitata;
[0161] - an agent with global anti-aging action, particularly anti-pigment spots, in particular niacinamide or vitamin B3;
[0162] - an antibacterial and / or sebum regulating agent, and / or sebum absorber such as retinoids, sarcosine, zinc salts, in particular zinc gluconate, zinc salicylate, azelaic acid, and / or their derivatives and mixtures, an extract of Orthosiphon stamineus marketed under the name MAT XS™ Bright by the applicant, an extract of Bixa Orellana marketed under the name Bix'Activ™ by the applicant, the antibacterial extracts described in patent application FR2863893, and in particular an extract of Boldo, in particular that marketed under the name Betapur™ by the applicant, or talc, and any of their mixtures. According to a preferred embodiment of the invention, the spheres are formulated with a makeup base conventionally called a “primer”, which may contain pigments and / or mica.
[0163] According to an alternative embodiment of the invention, the spheres are formulated in a cosmetic composition in combination with a cosmetic active ingredient as previously listed, preferably chosen from agents modifying the color of the skin and / or the radiance of the skin such as whitening agents, anti-aging agents, in particular those acting on photo-induced aging, moisturizers, anti-pollution, in particular antioxidant, soothing, sebum regulators and / or absorbers, mattifying, prebiotic, cosmetic active acting on imperfections of the surface and / or relief and / or color of the skin, antibacterial, and / or agent for sensitive skin.
[0164] More preferably, the spheres according to the invention are in a cosmetic composition containing at least one ingredient chosen from makeup pigments, mica, a moisturizing agent, an anti-aging agent and / or an agent acting on imperfections in relief, color and / or surface of the skin and / or their mixtures, more preferably a moisturizing agent and / or an anti-aging agent.
[0165] Advantageously, the cosmetic composition according to the invention contains at least one cosmetic excipient and / or a cosmetic pigment and / or colorant and / or a UV filter and / or an anti-blue light filter and / or a cosmetic active ingredient, preferably chosen from agents modifying the color of the skin and / or the radiance of the skin such as whitening agents, anti-aging agents, in particular those acting on photo-induced aging, moisturizers, anti-pollution, in particular antioxidant, soothing, sebum regulators and / or absorbers, mattifying, prebiotic, cosmetic active acting on imperfections of the surface and / or relief and / or color of the skin, antibacterial, and / or agent for sensitive skin.The use of the porous spheres according to the present invention is particularly advantageous in that it allows an immediately effective and lasting action on all types of skin including the scalp, on the cutaneous appendages, preferably the hair and on the mucous membranes in particular skin presenting unsightly manifestations or signs of discomfort.
[0166] Preferably, the porous spheres according to the invention, preferably in the form of a cosmetic composition according to the invention, are applied to at least one area of the body where there are unsightly and / or uncomfortable manifestations, this or these areas being preferably a surface of the body chosen from the skin of the face, including the forehead, cheeks, nose, temples, the so-called "T" zone (forehead, nose and chin), under the eyes, the peri-orbital zone, in particular the dark circles, the chin, the scalp, the neck, the back, the shoulders, the arms, the forearms, the thorax, the hands, the hair, the beard, the eyelashes, the eyebrows, the bust, in particular the décolleté, the stomach and / or the armpits, the legs, the feet, the hands, the neck, the thighs, the hips, the buttocks, the waist, the torso, the lip contour, the hair, the hair and / or the ocular mucosa, labial and / or buccal, preferably the skin of the face, hands,of the neckline.,
[0167] The present invention thus also relates to a cosmetic care method, advantageously non-therapeutic, for improving the appearance and / or comfort of the skin, skin appendages, in particular the hair, and / or mucous membranes, comprising the topical application to at least one area of skin and / or mucous membranes and / or skin appendages, in particular the hair, of the porous spheres according to the invention, preferably on at least one surface chosen from a surface of the body chosen from the skin of the face, including the forehead, cheeks, nose, temples, the so-called "T" zone (forehead, nose and chin), under the eyes, the peri-orbital zone, in particular the dark circles, of the chin, scalp, neck, back, shoulders, arms, forearms, thorax, hands, hair, beard, eyelashes, eyebrows, bust, in particular the décolleté, stomach and / or armpits, legs, feet, , hands, neck, thighs, hips, buttocks,of the waist, torso, lip contour, hair, hair and / or ocular, labial and / or buccal mucosa, preferably the skin of the face, hands, décolleté.,
[0168] The spheres according to the invention are particularly suitable for use on all types of skin, mucous membranes and / or appendages, in particular Caucasian, Asian, African as well as on all types of skin, in particular sensitive skin, atopic-prone skin, oily skin. They are particularly suitable for masking the first unsightly signs of aging, in particular the first expression lines and / or for mature skin, i.e. men or women aged at least 50, in particular postmenopausal women.
[0169] The cosmetic compositions according to the invention are preferably of the leave-in type.
[0170] Advantageously, the porous spheres according to the invention, preferably in the form of a composition intended for topical application, preferably cosmetic according to the invention, are used in regular topical application and preferably at least once a day, advantageously twice a day. Preferably, the cosmetic composition is applied to the skin.
[0171] The spheres can be used in powder form but also in the form of a cosmetic ingredient formulated in liquid form. For their formulation as a cosmetic ingredient, the spheres are then preferably suspended in glycerin and / or in another solvent, in particular a polar solvent such as water, alcohols, in particular propanediol, glycols in particular butylene glycol, propylene glycol, polyols or a mixture thereof, preferably a hydroglycolic mixture, still preferably containing a glycol chosen from butylene glycol, propylene glycol, caprylyl glycol, hexylene glycol and mixtures thereof. In a particularly advantageous manner, the spheres according to the invention are suspended in an aqueous solution containing glycerin, hexylene glycol, caprylyl glycol or a mixture thereof.
[0172] Advantageously, the invention also relates to a cosmetic treatment method for improving the appearance and / or comfort of the skin, skin appendages, in particular the hair, and / or mucous membranes, of an individual who needs / wants it, comprising the steps:
[0173] - The identification on the individual of an area of skin and / or mucous membranes and / or cutaneous appendages, the appearance and / or comfort of which must be improved and / or presenting unsightly manifestations to be hidden, and
[0174] - The topical application to this area of skin and / or mucous membranes and / or cutaneous appendages of a cosmetic composition containing the spheres according to the invention in an effective amount to improve the appearance and / or comfort of this area of skin and / or mucous membranes and / or cutaneous appendages, preferably hair, namely advantageously in a content of spheres of between 1 x 10 3at 100% by weight, and advantageously ranging from lxlO -2 at 95%, preferably ranging from 0.01% to 80%, more preferably from 0.05% up to 50%, more preferably from 0.1% up to 30%, more preferably up to 20%, more preferably up to 10%, and more preferably from 0.5% to 5% by weight relative to the total weight of the composition.
[0175] The spheres according to the invention can also be used to improve the comfort of the skin, mucous membranes and / or cutaneous appendages presenting a pathology.
[0176] The skin, mucous membranes and / or cutaneous appendages are preferentially altered, in particular in the context of a pathology chosen from the group consisting of reactive, inflammatory, atopic skin, hyperpigmented, hypopigmented, hyperseborrheic skin, in particular skin affected by vitiligo, melanoma, rosacea, telangiectasia, acne, rosacea, urticaria, psoriasis, herpes, impetigo, ecthyma, erysipelas, and / or presenting wounds and / or scars in particular acne, spots, boils, varicose veins, melasma, folliculitis, abscesses, any of their combinations.
[0177] In a preferred embodiment of the invention, the spheres according to the invention are in the form of a pharmaceutical composition further comprising a pharmaceutically acceptable excipient and are present in the pharmaceutical composition in a sphere content of between 1x10 3at 100% by weight, and advantageously ranging from lxlO -2 at 95%, preferably ranging from 0.01% to 80%, more preferably from 0.05% up to 50%, more preferably from 0.1% up to 30%, more preferably up to 20%, more preferably up to 10%, and more preferably from 0.5% to 5% by weight relative to the total weight of the composition.
[0178] Other aims, characteristics and advantages of the invention will become clear to those skilled in the art upon reading the explanatory description which refers to examples which are given solely by way of illustration and which in no way limit the scope of the invention.
[0179] The examples are an integral part of the present invention and any feature appearing new over any prior art from the description taken as a whole, including the examples, is an integral part of the invention in its function and in its generality. Thus, each example has a general scope. Furthermore, in the examples, all percentages are given by weight unless otherwise indicated, the temperature is expressed in degrees Celsius unless otherwise indicated, and the pressure is atmospheric pressure unless otherwise indicated.
[0180] Brief description of the drawings
[0181] Figure 1A represents a cross-sectional view of a sphere according to the invention with closed porosity and Figure 1B a view of a porous sphere of the prior art, in particular according to applications WO2020 / 183108 and WO2020 / 182936.
[0182] Figure 2 shows an SEM image of a porous sphere according to the invention obtained according to Example 1 (top image) as well as a cross-section of this sphere (bottom image).
[0183] Figure 3 shows an SEM image of a porous sphere according to the invention obtained according to example 2 (top image) as well as a cross-section of this sphere (bottom image).
[0184] Figure 4 shows an SEM image of a porous sphere according to the invention obtained according to Example 7.
[0185] EXAMPLES
[0186] Example 1: Porous silica spheres with closed porosity according to the invention
[0187] An aqueous dispersion of positively charged poly(meth)acrylate nanoparticles of diameter D 50of 210nm measured by dynamic light scattering (DLS) was diluted to 1% (w / w) with deionized water and 3% (w / w) negatively charged silica nanoparticles with a diameter D5o of 7nm measured by SEM were added. The mixture was sonicated for 30 seconds to prevent agglomeration. The nanoparticle-charged dispersion and the oil phase (continuous oil phase containing 2% (w / w) polyethylene glycol-co-perfluoro polyester surfactant in fluorinated oil) were each injected into a microfluidic device with a junction to obtain a droplet size of 50 pm via syringes associated with pumps. The whole is left at equilibrium until monodisperse droplets are produced. These are then collected in a reservoir.
[0188] The collected droplets are then dried in an oven at 50°C for 4 hours to provide dry spheres (dry powder). These spheres are then calcined by placing them on a silicone plate, and heating them from room temperature to 500°C for a period of 4 hours, then maintaining the temperature at 500°C for 2 hours. The spheres are allowed to cool at room temperature for 4 hours. The resulting porous monodisperse silica oxide spheres with closed porosity have an average diameter of 15 microns measured by scanning electron microscopy (SEM) and an average porosity measured by mercury porosimetry of 0.55.
[0189] An SEM image of one of the obtained spheres (top image) and its cross-section (bottom image) is shown in Figure 2. The cross-section clearly shows the interior of the sphere structure comprising a relatively monodisperse and ordered network of closed pores. 97% by volume of the pores in these spheres are closed pores.
[0190] Alternatively, Example 1 may be repeated by carrying out the drying step by microwave irradiation, vacuum drying and / or in the presence of a dehydrating agent.
[0191] Example 2: Porous silica spheres with closed porosity according to the invention obtained by atomization
[0192] An aqueous suspension of positively charged spherical nanoparticles of methyl methacrylate copolymer and 2-(methacryloyloxy)ethyl]trimethylammonium chloride having a diameter D 50measured by dynamic light scattering (DLS) measurement of 210 nm and negatively charged silica nanoparticles (average diameter measured by scanning electron microscopy (SEM) of 7 nm) was prepared. The aqueous suspension contains a content of 2.25 wt% of copolymer nanoparticles and a content of 0.75 wt% of silica nanoparticles, relative to the total weight of the suspension (weight ratio copolymer nanoparticles: silica nanoparticles = 3:1).
[0193] The aqueous suspension is spray-dried under nitrogen atmosphere (inlet temperature: 100°C, outlet temperature: 45°C, feed rate: 10mL / min, atomizing gas pressure 40 mm) using a BÜCHI laboratory-size atomizer.
[0194] The obtained microspheres are then calcined in a muffle furnace, in order to sinter and densify the silica nanoparticles and remove the polymer, by placing them on a silicone plate and carrying out a temperature increase from room temperature to 550°C for a period of 5 hours, then maintaining the temperature at 550°C for 2 hours, and finally lowering the temperature from 550°C to room temperature for a period of 3 hours. The monodisperse SiCh closed-porosity porous microspheres thus obtained have an average diameter of 2.9 pm (with a standard deviation of 1.5 pm) measured by scanning electron microscopy (SEM), an average pore diameter of 165 nm measured by scanning electron microscopy (SEM) and an average porosity measured by mercury porosimetry of 0.55. 94% by volume of the pores in these spheres are closed pores.
[0195] Another sphere was obtained having an average diameter of 2.9 pm and an average pore diameter of 210 nm was obtained according to the same protocol by simply changing the nanoparticle content: The aqueous suspension used contained a content of 2.25 wt% of copolymer nanoparticles and a content of 0.75 wt% of silica nanoparticles, relative to the total weight of the suspension (weight ratio copolymer nanoparticles: silica nanoparticles = 3:1) An SEM image of one of the spheres obtained (top image) as well as its cross-section (bottom image) is presented in Figure 3. The cross-section clearly shows the interior of the sphere structure comprising a relatively monodisperse and ordered network of closed pores. 96% by volume of the pores in these spheres are closed pores.
[0196] Example 3: Porous silica spheres with closed porosity according to the invention obtained by atomization
[0197] An aqueous suspension of positively charged spherical nanoparticles of methyl methacrylate and 2-(methacryloyloxy)ethyl]trimethylammonium chloride copolymer having a D5o diameter measured by dynamic light scattering (DLS) measurement of 210 nm and negatively charged silica nanoparticles (average diameter measured by scanning electron microscopy (SEM) of 7 nm) was prepared. The aqueous suspension contains a content of 7.5 wt% of copolymer nanoparticles and a content of 2.5 wt% of silica nanoparticles, relative to the total weight of the suspension (weight ratio copolymer nanoparticles: silica nanoparticles = 3:1).
[0198] The aqueous suspension is spray-dried under nitrogen atmosphere (inlet temperature: 100°C, outlet temperature: 45°C, feed rate: 10mL / min, atomizing gas pressure 40 mm) using a BÜCHI laboratory-size atomizer.
[0199] The obtained microspheres are then calcined in a muffle furnace, in order to sinter and densify the silica nanoparticles and remove the polymer, by placing them on a silicone plate and carrying out a temperature increase from room temperature to 550°C for a period of 5 hours, then maintaining the temperature at 550°C for 2 hours, and finally lowering the temperature from 550°C to room temperature for a period of 3 hours. The monodisperse porous closed-porosity SiCh microspheres thus obtained have an average diameter of 7.6 pm (with standard deviation of 3.5 pm) measured by scanning electron microscopy (SEM), an average pore diameter of 165 nm measured by scanning electron microscopy (SEM) and an average porosity measured by mercury porosimetry of 0.55. At least 90% by volume of the pores in these spheres are closed pores.
[0200] Example 4: Porous silica spheres with closed porosity according to the invention containing carbon black
[0201] The product of Example 1 was physically mixed with an aqueous dispersion of carbon black or a carbon black powder at different weight contents. The resulting porous spheres contained carbon black at a content of 0.5%, 1%, 2%, 3%, 4% and 5% by weight, based on the total weight of the particles.
[0202] Example 5: Variation of sphere colors
[0203] A quantity of 0.5 mg of porous spheres of Example 1 are placed in a 20 ml clear glass vial having a bottom surface area of 6 cm 2 The blue color is observed with the naked eye.
[0204] A sample of porous spheres is prepared according to Example 1 except that the weight ratio of polymer / silica is 2 / 1. The prepared sample has a green color observable to the naked eye.
[0205] Example 6: porous titanium spheres
[0206] An aqueous suspension of negatively charged spherical polystyrene nanoparticles having a diameter D 50 measured by dynamic light scattering (DLS) measurement of 197 nm and positively charged titanium nanoparticles (average diameter measured by scanning electron microscopy (SEM) of 15 nm) was prepared. The aqueous suspension contains a content of 1.8 wt% of polymer nanoparticles and a content of 1.2 wt% of titanium nanoparticles, relative to the total weight of the suspension (weight ratio polymer nanoparticles: titanium nanoparticles = 3:2).
[0207] The aqueous suspension is spray-dried under nitrogen atmosphere (inlet temperature: 100°C, outlet temperature: 45°C, feed rate: 10mL / min, atomizing gas pressure 55 mm) using a BÜCHI laboratory-sized atomizer. The obtained microspheres are then calcined in a muffle furnace, in order to sinter and densify the titanium nanoparticles and remove the polymer, by placing them on a silicone plate and carrying out a temperature rise from room temperature to 300°C for a period of 4 hours, then maintaining the temperature at 300°C for 6 hours, then carrying out a temperature rise to 550°C for a period of 2 hours, then maintaining the temperature at 550°C for 2 hours, and finally lowering the temperature from 550°C to room temperature for a period of 4 hours.The thus obtained porous TiCh closed porosity microspheres have an average diameter of 2.8 pm measured by scanning electron microscopy (SEM) with a standard deviation of 1.5 pm, an average pore diameter of 142 nm with a standard deviation of 15 nm measured by scanning electron microscopy (SEM) and an average porosity measured by mercury porosimetry of 0.55. 95% by volume of the pores of these spheres are closed pores.
[0208] Example 7: Porous silica spheres with closed porosity according to the invention obtained by sol-gel process
[0209] An aqueous suspension of positively charged spherical nanoparticles of methyl methacrylate and 2-(methacryloyloxy)ethyl]trimethylammonium chloride copolymer having a D5o diameter measured by dynamic light scattering (DLS) of 254 nm and the precursor tetramethyl orthosilicate silica (TMOS) was mixed at a pH in the range 2-5. The aqueous suspension contains a content of 1.8 wt% of copolymer nanoparticles and a content of 3.6 wt% of TMOS, based on the total weight of the suspension (weight ratio copolymer nanoparticles:TMOS = 1:3).
[0210] The aqueous suspension is spray-dried under nitrogen atmosphere (inlet temperature: 100°C, outlet temperature: 45°C, feed rate: 10mL / min, atomizing gas pressure 40 mm) using a BÜCHI laboratory-size atomizer.
[0211] The resulting microspheres are then calcined in a muffle furnace, in order to convert the silica precursor into silica nanoparticles, densify the silica and remove the polymer, by placing them on a silicone plate and heating from room temperature to 200°C for a period of 3 hours, then maintaining the temperature at 200°C for 2 hours, then heating to 550°C for a period of 2 hours, then maintaining the temperature at 550°C for 2 hours, and finally lowering the temperature from 550°C to room temperature for a period of 3 hours.The thus obtained porous SiO2 closed porosity microspheres have an average diameter of 3 pm with a standard deviation of 1.7 pm measured by scanning electron microscopy (SEM), an average pore diameter of 212 nm with a standard deviation of 15 nm measured by scanning electron microscopy (SEM) and an average porosity measured by mercury porosimetry ranging from 0.5 to 0.065. 90% by volume of the pores of these spheres are closed pores.
[0212] An SEM image of one of the obtained spheres is shown in Figure 4.
[0213] Example 8: Porous silica spheres with closed porosity according to the invention with pores of disordered sizes
[0214] An aqueous suspension of positively charged spherical nanoparticles of methyl methacrylate copolymer and 2-(methacryloyloxy)ethyl]trimethylammonium chloride of two different sizes (diameter D 50measured by dynamic light scattering (DLS) measurement of 254 nm and 142 nm) and negatively charged silica nanoparticles (diameter D 50 measured by dynamic light scattering (DLS) measurement of 7 nm) was prepared. The aqueous suspension contains a total content of 1.8% by weight of copolymer nanoparticles (0.9% of each size) and a content of 0.6% by weight of silica nanoparticles, relative to the total weight of the suspension (weight ratio copolymer nanoparticles: silica nanoparticles = 3:1).
[0215] The aqueous suspension is spray-dried under nitrogen atmosphere (inlet temperature: 100°C, outlet temperature: 45°C, feed rate: 10mL / min, atomizing gas pressure 40 mm) using a BÜCHI laboratory-size atomizer.
[0216] The obtained microspheres are then calcined in a muffle furnace, in order to sinter and densify the silica nanoparticles and remove the polymer, by placing them on a silicone plate and carrying out a temperature increase from room temperature to 550°C for a period of 6 hours, then maintaining the temperature at 550°C for 2 hours, and finally lowering the temperature from 550°C to room temperature for a period of 4 hours. The porous microspheres with closed porosity of SiCh thus obtained have an average diameter of 2 pm measured by scanning electron microscopy (SEM). They have a bimodal distribution of average pore diameter estimated at 165 nm. 93% by volume of the pores of these spheres are closed pores.
[0217] A quantity of 0.5 mg of porous spheres thus obtained are placed in a 20 ml clear glass vial having a bottom surface of 6 cm 2The angle-independent blue color is observed with the naked eye.
[0218] Example 9: evaluation of the improvement of the “soft focus” property by a cosmetic composition according to the invention
[0219] The spheres obtained according to Example 3 with an average diameter measured by scanning electron microscopy (SEM) of 7.6 pm, an average pore diameter measured by scanning electron microscopy (SEM) of 165 nm and a porosity of 0.55 (Ex 3) were incorporated into the oil-based formulation indicated in Example 10 below in a content of 1.5% by weight relative to the total weight of the formulation. The spheres obtained according to Example 2 with an average diameter D 50measured by scanning electron microscopy (SEM) of 2.9 pm, average pore diameter measured by scanning electron microscopy (SEM) of 165 nm and porosity 0.55 (Ex 2) were incorporated into the oil-based formulation indicated in Example 10 below at a content of 1% by weight relative to the total weight of the formulation.
[0220] The optical properties of transmittance and diffusion (haze) of these formulations were measured and compared with those measured for porous spheres described in application W02020183108 (open porosity) whose % of closed pores by volume is less than 5%:
[0221] - spheres with an average diameter measured by scanning electron microscopy (SEM) of 6.7 pm, an average pore diameter measured by scanning electron microscopy (SEM) of 153 nm and a porosity of 0.55 (Ex Comp 3) incorporated into the oil-based formulation indicated in Example 10 below in a content of 1.5% by weight relative to the total weight of the formulation.
[0222] - spheres with an average diameter measured by scanning electron microscopy (SEM) of 2.6 pm, an average pore diameter measured by scanning electron microscopy (SEM) of 153 nm and a porosity of 0.55 (Ex Comp 2) incorporated into the oil-based formulation indicated in Example 10 below in a content of 1% by weight relative to the total weight of the formulation, with vigorous stirring.
[0223] Measurements were performed after placing 3 ml of formulation on a glass plate (3 samples per formulation) and allowing it to dry for at least 1 hour. Total transmittance and scattering (Haze) measurements were performed by the BYK-Gardner haze-gard device (BYK-Gardner GmbH Germany).
[0224] The results are collected in Table 1 below.
[0225] [Table 1]
[0226] The spheres according to the invention have a higher total transmittance and haze value than those of the prior art, thus improving their blurring / masking / soft focus properties. In fact, particles having a “soft focus” effect must exhibit properties of:
[0227] - high total transmittance to give a natural appearance and
[0228] - maximum diffusion (“haze”) to form a translucent and uniform distribution of light.
[0229] Example 10: Oil-based formulation used in Example 8
[0230] It is an emulsion. Its composition is shown in Table 2 below.
[0231] [Table 2]
[0232] The emulsion is prepared by the usual methods in the field well known to those skilled in the art, by heating phases A and B separately to 75-80°C with stirring. Phase C is added to phase A with stirring and when the phases are homogeneous, phase B is added to phase AC with stirring until completely dispersed. The mixture is left to cool with gentle stirring to room temperature and the compounds of the additional phases are added, one after the other. The whole is homogenized for 2 min. The pH is adjusted to 5.2.
[0233] Example 10: cosmetic compositions according to the invention The porous spheres used are those obtained in examples 1 to 7 in powder form.
[0234] Example lOaj: Fluid emulsion for the face
[0235] [Table 3]
[0236] The emulsion is prepared by the usual methods in the field well known to those skilled in the art, by introducing phase B into phase A and stirring until completely dispersed. The mixture is heated to 75-80°C as is phase C separately. Then phase C is added to the mixture with stirring. The mixture is left to cool with gentle stirring to room temperature and the compounds of phases E and F are added, one after the other. The whole is homogenized for 2 min. The pH is adjusted to 5.2.
[0237] Example 10b): Face cream [Table 4]
[0238] The cream is prepared by the usual methods in the field well known to those skilled in the art, by mixing phases A and B previously heated to 75°C, then adding phases C and D while mixing and adjusting the composition with phase E to a pH of 6.2 and a viscosity of 15,000 mPas (measured with a Brookfield apparatus (RVT; 23°C, spindle TC; 20 rpm). Example 10c 1 ) : shampoo
[0239] [Table 5]
[0240] The shampoo is prepared by the usual methods in the field well known to those skilled in the art, by mixing the 4 phases and adjusting the composition to a pH of 5.2 and a viscosity of 2200 mPas (measured with a Brookfield apparatus (RVT; 23°C, spindle 5; 50 rpm).
Claims
Demands 1. Non-therapeutic cosmetic use of closed-porosity porous spheres comprising a metal oxide to improve the appearance and / or comfort of the skin, skin appendages, including hair, and / or mucous membranes.
2. Use according to claim 1, characterized in that at least 90% by volume of the pores of the spheres are closed pores, advantageously at least 95% by volume of the pores are closed pores.
3. Use according to any one of claims 1 or 2, characterized in that the spheres have an average diameter measured by scanning electron microscopy (SEM) ranging from 1 pm to 100 pm and / or an average porosity ranging from >0.10 to 0.80 and / or an average pore diameter measured by scanning electron microscopy (SEM) ranging from 50 nm to 800 nm, advantageously from 50 nm to 500 nm.
4. Use according to any one of the preceding claims, characterized in that the spheres have an average diameter measured by scanning electron microscopy (SEM) ranging from 1 pm to 100 pm and an average porosity ranging from >0.10 to 0.80 and an average pore diameter measured by scanning electron microscopy (SEM) ranging from 50nm to 800nm.
5. Use according to any one of the preceding claims, characterized in that the metal oxide is silicon oxide, titanium oxide, aluminum oxide, zirconium oxide, cerium oxide, iron oxide, zinc oxide, indium oxide, tin oxide, chromium oxide, mixed metal oxide and combinations thereof.
6. Use according to the preceding claim, characterized in that the metal oxide is chosen from the group consisting of SiO2, TiO2, ZnO and their mixtures, advantageously it is SiO2.
7. Use according to any one of the preceding claims, characterized in that the porous spheres comprise from 60% by weight to 99.9% by weight of metal oxide and from 0.1% by weight to 40% by weight of light-absorbing agents, in total weight of the spheres, advantageously from 0.1% by weight to 40% by weight of carbon black.
8. Use according to any one of the preceding claims, characterized in that the spheres have an average diameter measured by scanning electron microscopy (SEM) ranging from 1 pm to 75 pm and an average porosity ranging from 0.45 to 0.
70.
9. Use according to any one of the preceding claims characterized in that the spheres have an average diameter measured by scanning electron microscopy (SEM) ranging from 2.5 pm to 8 pm, an average porosity ranging from 0.45 to 0.70 and an average diameter measured by scanning electron microscopy (SEM) of pores ranging from 100 nm to 200 nm.
10. Use according to any one of the preceding claims to reduce the visibility of unsightly manifestations of the skin, skin appendages and / or mucous membranes, in particular irregularities in the relief and / or texture of the skin, mucous membranes and / or skin appendages, and / or irregularities in the color of the skin and / or mucous membranes.
11. Use according to any one of the preceding claims, wherein the spheres are present in a cosmetic composition, at a concentration ranging from 1x10 3 at 100% by weight, preferably from 0.5% to 5% by weight relative to the total weight of the composition.
12. Use according to the preceding claim to further improve the organoleptic properties of the cosmetic composition.
13. A cosmetic treatment procedure to improve the appearance and / or comfort of the skin, skin appendages, including hair, and / or mucous membranes, comprising topical application to at least one area of skin and / or skin appendages and / or mucous membranes of closed-porosity porous spheres comprising a metallic oxide and / or a cosmetic composition comprising them.
14. Cosmetic care method according to claim 13, characterized in that the spheres are as described in any one of claims 1 to 9 and 11.
15. Cosmetic treatment method according to any one of claims 13 or 14, for reducing the visibility of unsightly manifestations of the skin, skin appendages and / or mucous membranes, in particular irregularities in the relief and / or texture of the skin, mucous membranes and / or skin appendages, and / or irregularities in the color of the skin and / or mucous membranes.
16. A cosmetic treatment method according to any one of claims 13 to 15, characterized in that at least one area of skin and / or skin appendages and / or mucous membranes is selected from the skin of the face, including the forehead, cheeks, nose, temples, the so-called "T-shaped" area (forehead, nose, and chin), under the eyes, the periorbital area, in particular dark circles, the chin, scalp, neck, back, shoulders, arms, forearms, chest, hands, hair, beard, eyelashes, eyebrows, torso, in particular the décolleté, abdomen and / or armpits, legs, feet, hands, neck, thighs, hips, buttocks, waist, torso, lip contour, hair, and / or the ocular, labial, and / or oral mucosa, preferably the skin of the face, hands, and / or the low-cut.
17. A cosmetic or pharmaceutical composition, in particular dermatological, characterized in that it contains closed-porosity porous spheres as described in any one of claims 1 to 9 at a concentration ranging from 1 to 10 3 at 10% by weight, preferably from 0.5% to 5% by weight relative to the total weight of the composition.
18. Cosmetic composition according to the preceding claim characterized in that it contains at least one cosmetic excipient and / or a cosmetic pigment and / or colorant and / or a UV filter and / or a cosmetic active ingredient, preferably chosen from agents modifying skin color and / or skin radiance such as whitening agents, anti-aging agents, in particular those acting on photo-induced aging, moisturizers, anti-pollution agents, in particular antioxidants, soothing agents, sebum regulators and / or absorbers, mattifying agents, prebiotics, cosmetic actives acting on imperfections of the surface and / or texture and / or color of the skin, antibacterial agents, and / or agents for sensitive skin.
19. Cosmetic composition according to claim 17 or 18, characterized in that it is in the form of a serum, lotion, cream, shampoo, conditioner, oil, milk, ointment, paste, mousse, emulsion, hydrogel, shower gel, mask, lacquer, spray, wax, powder, in particular makeup, or stick.
20. Cosmetic composition according to any one of claims 17 to 19, characterized in that it is in the form of a slightly gelled composition and / or comprises an oily phase, preferably it is of the oily composition type or oil-in-water or water-in-oil emulsion or lotion type.
21. Pharmaceutical composition, in particular dermatological, according to claim 17, for use in improving the comfort of skin, skin appendages and / or mucous membranes exhibiting a pathology, in particular manifesting as a loss of homogeneity and / or dysregulation and / or irregularity of color, tone, sebum secretion and / or texture, such as hyperpigmented, hypopigmented, hyperseborrheic, reactive, inflammatory, atopic skin, in particular skin affected by vitiligo, melanoma, the couperose, telangiectasia, acne, rosacea, urticaria, psoriasis, herpes, impetigo, ecthyma, erysipelas, and / or presenting with wounds and / or scars, including acne, pimples, boils, varicose veins, melasma, folliculitis, abscesses, or any combination thereof.
